Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Phosphomannose isomerase (PMI) deficiency is the cause of a new type of carbohydrate-deficient glycoprotein syndrome (CDGS). The disorder is caused by mutations in the PMI1 gene. The clinical phenotype is characterized by protein-losing enteropathy, while neurological manifestations prevailing in other types of CDGS are absent. Using standard diagnostic procedures, the disorder is indistinguishable from CDGS type Ia (phosphomannomutase deficiency). Daily oral mannose administration is a successful therapy for this new type of CDG syndrome classified as CDGS type Ib.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type I
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01357-1 · Cited by 359 · cited 6×
“ing to a procedure by van Schaftingen and Jaeken (6).”
BackgroundMethodInfluentialJaeken, J., Vanderschueren-Lodeweyckx, M., Casaer, P., Snoeck, L., Corbeel, L., Eggermont, E., & Eeckels, R. (1980) · Pediatric Research · doi:10.1203/00006450-198002000-00117 · Cited by 287 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Panneerselvam, K., & Freeze, H. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118570 · Cited by 146 · cited 1×
“Based on studies showing that mannose could correct abnormal glycosylation in CDGS type Ia fibroblasts (15), mannose therapy was initiated and followed up for 11 mo.”
BackgroundSelf-citationThe X-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 Å resolution
Cleasby, A., Wonacott, A. J., Skarzynski, T. J., Hubbard, R. E., Davies, G. J., Proudfoot, A. E. I., Bernard, A. R., Payton, M. A., & Wells, T. N. C. (1996) · Nature Structural Biology · doi:10.1038/nsb0596-470 · Cited by 115
Alton, G., Kjærgaard, S., Etchison, J. R., Skovby, F., & Freeze, H. H. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2574 · Cited by 111 · cited 1×
“In accordance with previous human ingestion studies (19), mannose was given orally in an initial dose of 100 mg/kg body wt three times a day.”
Self-citationCarbohydrate-Deficient Glycoprotein Syndrome - A Fourth Subtype
Stibler, H., Stephani, U., & Kutsch, U. (1995) · Neuropediatrics · doi:10.1055/s-2007-979762 · Cited by 92 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Purification cDNA cloning and heterologous expression of human phosphomannose isomerase
PROUDFOOT, A. E. I., TURCATTI, G., WELLS, T. N. C., PAYTON, M. A., & SMITH, D. J. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19954.x · Cited by 86 · cited 3×
“The sequence of the human PMI cDNA (10) was used to design primers for PCR amplification.”
BackgroundMethodInfluentialCarbohydrate-Deficient Glycoprotein (CDG) Syndrome - A New Variant, Type III
Stibler, H., Westerberg, B., Hanefeld, F. A., & Hagberg, B. (1993) · Neuropediatrics · doi:10.1055/s-2008-1071513 · Cited by 71 · cited 1×
“(1) Hexokinase; (2) glucose 6-phosphate dehydrogenase; (3) phosphoglucose isomerase; (4) phosphomannose isomerase; (5) phosphomannomutase; (6) GDPmannose synthase.”
Human Fibroblasts Prefer Mannose over Glucose as a Source of Mannose for N-Glycosylation
Panneerselvam, K., Etchison, J. R., & Freeze, H. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23123 · Cited by 70
Self-citationA novel Saccharomyces cerevisiae secretory mutant possesses a thermolabile phosphomannose isomerase
Payton, M. A., Rheinnecker, M., Klig, L. S., Detiani, M., & Bowden, E. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.6.2006-2010.1991 · Cited by 70 · cited 1×
“Phenotypic correction of the PMI deficiency in yeast was achieved by supplying 5 mM mannose together with glucose (20).”
Method
Cited by
Items 301–400 of 427
González-García, A., Kanli, M., Wisowski, N., Montoliu-Silvestre, E., Locascio, A., Sifres, A., Gómez, M., Ramos, J., Porcel, R., Andrés‐Colás, N., et al. (2023) · Plant Science · doi:10.1016/j.plantsci.2023.111897 · Cited by 5
Levy, J. F., Chung, W., Garzón, M. C., GALLAGHER, M. P., Oberfield, S. E., Lieber, E., & Anyane‐Yeboa, K. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10072 · Cited by 5
“This type of secretory diarrhea is classified as type 1B carbohydrate-deficient glycoprotein (CDG) and is caused by mutations in the PMI gene [Niehues et al., 1998].”
BackgroundCongenital Disorders of Glycosylation: A Review
Albahri, Z. (2015) · Asian Journal of Psychiatry · doi:10.11648/j.ajp.20150102.11 · Cited by 6
Variation of the serum N‐glycosylation during the pregnancy of a MPI‐CDG patient
Lebredonchel, E., Duvet, S., Douillard, C., Foulquier, F., & Klein, A. (2021) · JIMD Reports · doi:10.1002/jmd2.12247 · Cited by 5
Miwa, I., Taguchi, T., Asano, H., Murata, T., Yorifuji, T., Nagasaka, H., & Takatani, T. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.024 · Cited by 5
Biomarkers and diagnosis of congenital disorders of glycosylation
Denecke, J. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050902878023 · Cited by 8
“Phosphomannomutase II (PMM II/CDG Ia) and Phosphomannose isomerase (PMI/CDG Ib) activity can easily be determined using a spectrophotometric assay measuring the reduction of NADP to NADPH [1,33].”
MethodNoman, K., Hendriksz, C. J., Radcliffe, G. S., Roncaroli, F., Moreea, S., Hussain, A., & Stępień, K. M. (2020) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2020.100646 · Cited by 5
Congenital hepatic fibrosis—Is it really a matter of “a spoonful of sugar?”
Schwarzenberg, S. J. (1999) · Hepatology · doi:10.1002/hep.510300239 · Cited by 5
Diagnostic and Therapeutic Approaches in Congenital Disorders of Glycosylation
Raynor, A., Lebredonchel, E., Foulquier, F., Fenaille, F., & Bruneel, A. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_745 · Cited by 5
Ontogeny of d-Mannose Transport and Metabolism in Rat Small Intestine
Cano, M., & Ilundáin, A. A. (2010) · The Journal of Membrane Biology · doi:10.1007/s00232-010-9259-0 · Cited by 3
Congenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00013-4 · Cited by 5
Self-citationNagasaka, H., Yorifuji, T., Bandsma, R., Takatani, T., Asano, H., Mochizuki, H., Takuwa, M., Tsukahara, H., Inui, A., Tsunoda, T., et al. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9514-x · Cited by 4
Enteropathies of Infancy and Childhood
Russo, P. (2013) · Advances in Pediatrics · doi:10.1016/j.yapd.2013.04.010 · Cited by 4
Congenital protein hypoglycosylation diseases
Sparks, S. E. (2012) · The Application of Clinical Genetics · doi:10.2147/tacg.s18673 · Cited by 5
Anomalies congénitales de glycosylation
de Lonlay, P., Valayannopoulos, V., Dupré, T., Vuillaumier‐Barrot, S., & Séta, N. (2008) · Archives de Pédiatrie · doi:10.1016/s0929-693x(08)71847-5 · Cited by 4
Intractable Diarrhoea due to Congenital Enterocyte Defects
Phillips, A. D. (2005) · Annales Nestlé (English ed ) · doi:10.1159/000086496 · Cited by 4
Congenital Hepatic Fibrosis, Caroli’s Disease, and Other Fibrocystic Liver Diseases
Rock, N. M., Kanavaki, I., & McLin, V. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17169-2_57 · Cited by 4
Hong, J. G., Carbajal, Y., Trotman, J. C., Glass, M., Sclar, V., Alter, I. L., Zhang, P., Wang, L., Chen, L., Petitjean, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576067 · Cited by 4
Wrześniak, M., Kepinská, M., Bizoń, A., Milnerowicz-Nabzdyk, E., & Milnerowicz, H. (2015) · Fetal and Pediatric Pathology · doi:10.3109/15513815.2015.1095260 · Cited by 3
“Changes in the number of sialic acid residues have been observed during pregnancy and preeclampsia [5], alcohol abuse [6], carbohydrate deficiency syndrome [7], iron deficiency [8] and rheumatoid arthritis [9].”
BackgroundCongenital Disorders of Glycosylation
Jaeken, J., & Matthijs, G. (2003) · Springer eBooks · doi:10.1007/978-3-642-55878-8_26 · Cited by 3
Enteropathies Associated with Chronic Diarrhea and Malabsorption in Childhood
Russo, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-54053-0_4 · Cited by 4
Tapetoretinal degenerations: Experiences, experiments and expectations
Ehinger, B. (2000) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2000.078003244.x · Cited by 3
Perhaps a wee bit of sugar would help
Freeze, H. H. (2016) · Nature Genetics · doi:10.1038/ng.3600 · Cited by 3
Self-citationCongenital Disorders of N-linked Glycosylation
Patterson, M. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00060-7 · Cited by 3
Toward a Molecular Understanding of Complex Childhood Enteropathies
MURCH, S. H. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2002.tb07714.x · Cited by 3
Metabolism of Sugars and Sugar Nucleotides
Freeze, H. H. (2000) · Wiley eBooks · doi:10.1002/9783527618255.ch40 · Cited by 3
Self-citationMaintenance and loss of self-tolerance in B cells
Iglesias, A. (2001) · Springer Seminars in Immunopathology · doi:10.1007/s281-001-8164-3 · Cited by 2
Glycosylation: General Overview
Jaeken, J., & Carchon, H. A. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01501-1 · Cited by 5
Congenital Defects of Glycosylation: Disorders of N-Glycan Synthesis
Jaeken, J. (2000) · Springer eBooks · doi:10.1007/978-3-662-04285-4_38 · Cited by 4
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Hong, J. G., Trotman, J. C., Carbajal, Y., Dey, P., Glass, M., Sclar, V., Alter, I. L., Zhang, P., Wang, L., Chen, L., et al. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000671 · Cited by 6
Sousa, S. A., Ramos, C. G., Feliciano, J. R., & Leitão, J. H. (2010) · BiblioBoard Library Catalog (Open Research Library) · doi:10.5772/intechopen.83998 · Cited by 2
“01 ND ND Griffin et al., 1997 PMI Co2+>Mg2+>Ca2+> Ni2+>Zn2+ ND ND Mg2+ ND ND GDP-Dmannose Tran et al., 2009 aThe PMI reaction was performed in presence of MgCl 2 . bThe specific activity was determined in crude cell extracts of the E. coli CD1 (pmi-) and CWG152 (gmp-) strains.”
BackgroundInfluentialGlycosylation defects corrected by the changes in GDPmannose level.
Kruszewska, J. S., Janik, A., Lenart, U., & Palamarczyk, G. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4165 · Cited by 2
Protocolo de estudio en hepatopatías de etiología metabólica
Casanova, M. M.-P. (2003) · Anales de Pediatría · doi:10.1016/s1695-4033(03)78782-7 · Cited by 2
“Fibrosis hepática + enteropatía Diarrea secretoria + cirrosis Trastorno de glucosilación de proteínas, exudativa (12) tipo Ib: deficiencia de fosfomanosa isomerasa: el CDT es > 7 % (N< 5,4 %)”
BackgroundTreatment and management of patients with inherited metabolic diseases
Lee, J. (2006) · Korean Journal of Pediatrics · doi:10.3345/kjp.2006.49.11.1152 · Cited by 2
Diarrhées intraitables dues à des anomalies congénitales des entérocytes
Phillips, A. D. (2006) · Annales Nestlé (Ed française) · doi:10.1159/000093836 · Cited by 2
Eiweißverlierende Enteropathie
Lentze, M. J. (2003) · Springer eBooks · doi:10.1007/978-3-540-76460-1_113 · Cited by 2
Freeze, H. H., Ng, B., & Patterson, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00040-0 · Cited by 2
Self-citationCongenital Hepatic Fibrosis, Caroli’s Disease, and Other Fibrocystic Liver Diseases
Rock, N. M., Kanavaki, I., & McLin, V. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-80068-0_60 · Cited by 3
Congenital Disorders of Glycosylation
Körner, C., Lübbehusen, J., & Thiel, C. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_21 · Cited by 2
Self-citationFreeze, H. H. (2002) · Springer eBooks · doi:10.1007/978-4-431-67877-9_85 · Cited by 2
Self-citationRani, S., Sahai, I., & Misra, M. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad109 · Cited by 2
“…partial villous atrophy, elevated aminotransferases, hepatomegaly, portal hypertension, hep-atic fibrosis, hyperinsulinemic hypoglycemia, hypothyroidism, low antithrombin III activity, protein C, protein S or Factor IX deficiency, and thrombotic events as well as gastro-intestinal bleeding [3–6].”
BackgroundBiosynthesis and Degradation of Mono-, Oligo-, and Polysaccharides: Introduction
Wilson, I. B. H. (2008) · Springer eBooks · doi:10.1007/978-3-540-30429-6_58 · Cited by 2
Haznedar, P., & Eminoğlu, F. T. (2018) · Türk Pediatri Arşivi · doi:10.5152/turkpediatriars.2018.18004 · Cited by 2
“(5) on a 6-yearold patient, which successfully normalized the symptoms rapidly.”
BackgroundRetrospective diagnosis of carbohydrate‐deficient glycoprotein syndrome type Ib
Neele, D. M., Kneepkens, C. M. F., Verhoeven‐Duif, N. M., & Jakobs, C. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005699725822 · Cited by 2
“(New-born) Siblings of this boy can now be screened and treated if necessary, since mannose administration has been shown to be a successful therapy for CDGS Ib (Niehues et al 1998).”
BackgroundInfluentialSéta, N., Dupré, T., Cormier‐Daire, V., de Lonlay, P., Moore, S. E. H., Durand, G., & Codogno, P. (1999) · médecine/sciences · doi:10.4267/10608/1246 · Cited by 3
Impact of xylose and mannose on central metabolism of yeast Saccharomyces cerevisiae
Pitkänen, J. (2005) · Aaltodoc (Aalto University) · Cited by 3
Bezerra, J. A., & Balistreri, W. F. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70138-0 · Cited by 2
Disorders of Carbohydrate Metabolism
Radke, J., Bönnemann, C. G., Stenzel, W., & Goebel, H. (2018) · Wiley eBooks · doi:10.1002/9781119013112.ch28 · Cited by 2
A hypomorphic Mpi mutation unlocks an in vivo tool for studying global N-glycosylation deficiency
Lin, E., Meregini, S., Zhang, Z., Roy, A., Argula, T., Mitchell, J. M., Israelsen, W. J., Ludwig, S. M., Russell, J. L., Quan, J., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.180752 · Cited by 1
“Mpi deficiency (MPI-CDG) is one of the only glycosylation precursor defects treatable with carbohydrate supplementation (15, 28, 34).”
InfluentialOral D-mannose therapy during pregnancy in a woman with MPI-CDG: A case report and management review
Martzolff, L., Raynor, A., Lebredonchel, E., Marescaux, S., Desprez, D., Douillard, C., Fédérici, L., Alamome, I., Trillot, N., Alili, J., et al. (2025) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2025.109269 · Cited by 1
Enteropathies of Infancy and Childhood
Russo, P. (2010) · Surgical pathology clinics · doi:10.1016/j.path.2010.06.001 · Cited by 1
Genetisch bedingte Stoffwechselstörungen
Gärtner, J. (2005) · Elsevier eBooks · doi:10.1016/b978-343723390-6.50067-x · Cited by 1
Martín, J. A. S., Fajardo, A. A., & Ardila, J. A. U. (2020) · Revista Med · doi:10.18359/rmed.3358 · Cited by 1
“…mg de proteína) con respecto al límite inferior y más alto (40,3 nmol/min. mg de proteína) y al estudio rea-lizado en Múnich por Niehues et al. (35), quienes reportaron un valor de referencia para la enzima PMI de 16,6-20,04 nmol/min. mg de proteína con una actividad media de 18,1 nmol/min. mg…”
BackgroundInfluentialBehboudi, E., Shekaari, H., & Zafarani-Moattar, M. T. (2021) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2021.06.029 · Cited by 1
Biliary Atresia and Neonatal Disorders of the Bile Ducts
Mieli‐Vergani, G., & Hadžić, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00069-4 · Cited by 2
Other forms of congenital disorders of glycosylation
Nyhan, W., Hoffmann, G. F., Barshop, B., & Al-Aqeel, A. (2011) · CRC Press eBooks · doi:10.1201/b15310-119 · Cited by 1
Congenital Disorders of Glycosylation
Jaeken, J. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_41 · Cited by 1
Киселева, Т. Л., Киселева, М. А., & Хлебников, Е. В. (2024) · Традиционная медицина · doi:10.54296/18186173_2024_4_19 · Cited by 1
Trastornos congénitos de la glucosilación de las glucoproteínas séricas
de Lonlay, P., & Séta, N. (2009) · EMC - Pediatría · doi:10.1016/s1245-1789(09)70208-2 · Cited by 1
Angeborene Störungen des Kohlenhydratstoffwechsels und sonstige angeborene Stoffwechselstörungen
Muntau, A. C. (2014) · Springer eBooks · doi:10.1007/978-3-642-41814-3_15 · Cited by 1
Eiweißverlierende Enteropathie bei Kindern und Jugendlichen
Lentze, M. J. (2024) · Springer Reference Medizin · doi:10.1007/978-3-642-54671-6_155-3 · Cited by 1
Hellbusch, C. C. (2007) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-193 · Cited by 1
Diarrea intratable causada por anomalías congénitas de los enterocitos
Philips, A. D. (2006) · Annales Nestlé (Ed española) · doi:10.1159/000091005 · Cited by 1
“por otra parte, los pacientes con trastornos congenitos de la glucosilacion de tipo 1b presentaban diarrea grave y enteropatia con perdida de proteinas [”
BackgroundCarbohydrate-deficient glycoprotein syndrome et glycosylation des N-glycosylprotéines
Séta, N. (1999) · Archives de Pédiatrie · doi:10.1016/s0929-693x(99)80414-x · Cited by 1
Congenitale defecten van de glycosylering (cdg) anno 2000
Jaeken, J., & Carchon, H. A. (2001) · Tijdschrift voor kindergeneeskunde · doi:10.1007/bf03061351 · Cited by 1
GI Tract Enteropathies of Infancy and Childhood
Russo, P. (2009) · Elsevier eBooks · doi:10.1016/b978-141604059-0.50012-6 · Cited by 2
Ullrich, K., Schaub, J., Spranger, J. W., Kohlschütter, A., Bachmann, C., Harms, E., Wendel, U., Baerlocher, K. E., Böhles, H. J., Smeitink, J. A. M., et al. (2001) · Springer eBooks · doi:10.1007/978-3-662-12660-8_6 · Cited by 1
Self-citationCongenital Disorders of Glycosylation
Himmelreich, N., Lübbehusen, J., Körner, C., Lefeber, D. J., & Thiel, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-58819-8_17 · Cited by 1
Self-citationCongenital Disorders of Glycosylation (CDG) – CDG-Krankheiten
Tegtmeyer, L. C., & Marquardt, T. (2014) · Springer eBooks · doi:10.1007/978-3-642-45188-1_18
“Inkonstant können vorhanden sein: Mikrozephalie, Hirnfehlbildungen, muskuläre Hypotonie, verschiedene neurologische Symptome, Retinitis, Dysmorphiezeichen, Gerinnungsstörungen, gastrointestinale Symptome (chronische Diarrhö, Gedeihstörungen), Hepatopathie, Hypogonadismus, dilatative Kardiomyopathie [1, 3].”
BackgroundSelf-citationMannose Phosphate Isomerase (MPI)
Sharma, V., & Freeze, H. H. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_20
Self-citationGenetic Diseases of Glycosylation
Akama, T. O., & Fukuda, M. N. (2000) · Carbohydrates in Chemistry and Biology · doi:10.1002/9783527618255.ch97
Maeda, Y., & Morita, Y. S. (2009) · The Enzymes · doi:10.1016/s1874-6047(09)26005-7 · Cited by 1
Lübke, T. (2001) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-69
Molekulare Ursachen von Störungen des hepatogastroenterologischen Systems bei Neugeborenen
Bindl, L., Buderus, S., Dammann, S., & Lentze, M. J. (2005) · Springer eBooks · doi:10.1007/3-540-26524-4_16
[Carbohydrate-deficient glycoprotein syndrome and progression in electrophysiological results].
Bourcier, F., Billard, C., Toutain, A., & Delplace, M. P. (2002) · PubMed
Pajares, V., & Isabel, A. (2009) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Freeze, H. H., Srikrishna, G., Kim, S., Mehta, D. P., Dryhurst, K., & MURCH, S. H. (1998) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1998.tb01375.x
Self-citationIntraktable Diarrhoe aufgrund kongenitaler Enterozytendefekte
Phillips, A. D. (2006) · Annales Nestlé (Deutsche Aufl ) · doi:10.1159/000092811
“Patienten mit einer kongenitalen Storung der Glykolysierung vom Typ-1b leiden ferner unter schwerer Diarrhoe und Proteinverlustenteropathie [”
BackgroundGilbert, F. (1999) · Genetic Testing · doi:10.1089/109065799316653
Congenital Disorders of Glycosylation and Their Effects on the Liver
Eklund, E. A., & Freeze, H. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-524-8_12
“It is interesting to note that oligosaccharides released from LLO or glycoproteins synthesized by PMI-deficient fibroblasts are normal when compared to, for example, PMM2-deficient cells, in which truncated species are seen under selected culture conditions [ 21 ].”
BackgroundInfluentialSelf-citationKrankheiten von Verdauungstrakt, Peritoneum, Bauchwand und Pankreas
Reich, R., Hillmann, G., Koletzko, S., Lentze, M., Keller, K., Nützenadel, W., Waag, K., Henker, J., & Buderus, S. (2001) · Springer eBooks · doi:10.1007/978-3-662-12660-8_15
Determination of D-Mannose in Serum by Capillary
Carchon, H. A., & Jaeken, J. (2001)
Anomalies congénitales de glycosylation des glycoprotéines sériques
de Lonlay, P., & Séta, N. (2008) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(08)72416-5
Mannosephosphate Isomerase (MPI)
(2008) · Springer eBooks · doi:10.1007/978-1-4020-6754-9_9825
Other forms of congenital disorders of glycosylation
Nyhan, W., Barshop, B., & Ozand, P. (2005) · CRC Press eBooks · doi:10.1201/b13565-123
Вродени дефекти на гликозилиране
Станчева-Иванова, М. (2016) · Редки болести и лекарства сираци · doi:10.36865/2016.v7i2.52
Neurometabolische und neurodegenerative Erkrankungen
(2009) · Elsevier eBooks · doi:10.1016/b978-343723075-2.10006-8
Iron and Cell Proliferation: Mechanisms and Applications in Cancer Therapy
Testa, U. (2001) · CRC Press eBooks · doi:10.1201/b14262-5
Witköwski, R., Prokop, O., Ullrich, E., & Thiel, G. (2003) · Springer eBooks · doi:10.1007/978-3-642-55694-4_5
Congenital Disorder of Glycosylation (CDG) - Ih
Thiel, C. (2003) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-597
Angeborene Glykosylierungsstörungen
Marquardt, T. (2007) · Springer eBooks · doi:10.1007/978-3-540-76460-1_35
Self-citationFreeze, H. H., & Patterson, M. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00035-4
Self-citationAngeborene Störungen des Kohlenhydratstoffwechsels und sonstige angeborene Stoffwechselstörungen
Muntau, A. C. (2008) · Springer eBooks · doi:10.1007/978-3-540-71899-4_15
Eiweißverlierende Enteropathie bei Kindern und Jugendlichen
Lentze, M. J. (2019) · Springer Reference Medizin · doi:10.1007/978-3-642-54671-6_155-2
Diarrhoea, Hypoalbuminaemia, Hepatomegaly, Hypoglycaemia and Coagulopathy? Check for MPI-CDG!
Гусина, А. А., Криницкая, К. А., & Гусина, Н. Б. (2021) · Педиатрия Восточная Европа · doi:10.34883/pi.2021.9.1.011
Eiweißverlierende Enteropathie bei Kindern und Jugendlichen
Lentze, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-54671-6_155-1
Congenital disorders of N-linked glycosylation
Patterson, M. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00064-7
Glycosylation, Congenital Disorders of
Denecke, J. (2009) · Springer eBooks · doi:10.1007/978-3-540-29676-8_3419
Metadata
- Authors
- Niehues, R., Hasilik, M., Alton, G., Körner, C., Schiebe-Sukumar, M., Koch, H. G., Zimmer, K. P., Wu, R., Harms, E., Reiter, K., von Figura, K., Freeze, H. H., Harms, H. K., & Marquardt, T.
- Affiliations
- University Hospital Münster (DE)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of Göttingen (DE)
- Venue
- Journal of Clinical Investigation
- Published
- 1998-04-01
- Volume
- 101
- Issue
- 7
- Pages
- 1414-1420
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508719
- OpenAlex
- W1970122244
- Cited by
- 422
- References
- 20
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 13 · 2023: 11 · 2022: 8 · 2021: 14 · 2020: 16 · 2019: 7 · 2018: 12 · 2017: 12 · 2016: 4 · 2015: 13 · 2014: 18 · 2013: 7 · 2012: 14
- FWCI
- 22.32
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm049096-04)
- National Institute of General Medical Sciences (R01 GM49096)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- protein-losing enteropathy, phosphomannomutase deficiency
- MeSH terms
- Cells, Cultured, Glycoproteins, Glycosylation, Humans, Infant, Male, Mannose, Mannose-6-Phosphate Isomerase, Mutation, Protein Processing, Post-Translational, Protein-Losing Enteropathies, Syndrome, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.